Position in MRK
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$2,147,106
+$88,343 QoQ
Shares Held
16,709
-2.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#1,538
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Legacy Private Trust Co. holds $43,660,786 across 7 Drug Manufacturers - General names. MRK ranks #4 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
18,088 | $21,695,290 | |
| 2 | JNJ |
Johnson & Johnson
|
36,303 | $9,219,871 | |
| 3 | ABBV |
AbbVie Inc.
|
33,151 | $8,342,116 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
16,709 | $2,147,106 | |
| 5 | AMGN |
Amgen Inc
|
4,257 | $1,541,544 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,655 | $441,081 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,167 | $273,778 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,147,106 | 16,709 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $2,058,763 | 17,115 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $1,912,889 | 18,173 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $1,580,989 | 18,837 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $1,585,891 | 20,034 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $2,526,025 | 28,142 | Shares | Sole | 2025-04-04 | |
| 2024-12-31 | $2,837,667 | 28,525 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $2,919,741 | 25,711 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $3,116,541 | 25,174 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $3,470,285 | 26,300 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $3,034,571 | 27,835 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $2,911,940 | 28,285 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $3,366,272 | 29,173 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $3,339,901 | 31,393 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $4,908,538 | 44,241 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $3,775,759 | 43,843 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $3,588,177 | 39,357 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $2,861,575 | 34,876 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $2,543,834 | 33,192 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $2,559,898 | 34,082 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $2,591,995 | 33,329 | Shares | Sole | 2021-07-09 | |
| 2021-03-31 | $2,855,954 | 37,047 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $2,730,400 | 33,379 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $2,811,757 | 33,897 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $2,844,817 | 36,788 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $456,561 | 5,934 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||